Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-07-13 @ 4:52 AM
Study NCT ID:
NCT06553456
Status:
COMPLETED
Last Update Posted:
2025-09-30
First Post:
2024-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
Sponsor:
Protgen Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cirrhotic Ascites | View |
Keywords: